AFF1 and acute lymphoblastic leukemia: The VHR subset with an indication for HSCT was defined by: (1) Ph+ ALL or KMT2A-AFF1 fusion, (2) PPR plus T-ALL and/or a WBC count of 100,000/μl or greater, and (3) IF.